A full face, baseline controlled study to evaluate the efficacy of Dermapen 4™ microneedling device in conjunction with MG-CLR serum for acne treatment over 12 weeks. - NI

Equipmed USA LLC0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•Female subjects aged between 18-45 years (both ages inclusive).
•Fitzpatrick skin phototype I to VI.
•Subjects having IGA score of 2 and 3.
•Subjects who have not received any kind of treatment for acne 1 month before the start of the study.
•Subject free of excessive hair, cuts, abrasions, fissures, wounds, lacerations, or any other skin conditions on the face.
•Subjects who agree not to use any other product/treatment/home remedy/except the provided products on their face during the study period.
•Subjects who agree not to carry out bleaching or any other procedures including facial etc. on face during the study period.
•Subjects who agree not to expose to excessive sunlight. (Sun exposure not more than two hours daily and during that time use of an umbrella to cover the face).
•Subjects willing to give a voluntary written informed consent, photography release, and agree to come for regular follow-up.
•Subjects willing to abide by and comply with the study protocol.

•1.Subjects with known skin condition that may impact the assessment.
•2.Subjects with active Herpes labialis infection.
•3.Subjects known to have bleeding and clotting disorders (self-declared).
•4.Subjects known to have connective tissue disorders.
•5.Subjects with any other signs of significant local irritation or skin disease.
•6.Subjects currently taking any medication, which the investigator believes may influence the interpretation of the data.
•7.Subjects having clinically significant systemic or cutaneous disease, chronic illness or major surgery in the last year.
•8.Subjects undergoing treatment of any skin condition on their face.
•9.Subjects not willing to discontinue other topical facial products.
•10.Subjects who are allergic or sensitive to bar cleansing products, cosmetics, creams/lotions, artificial jewelry or anything else.
•11.Subjects who have participated in a similar clinical study 4 weeks before this study.
•12.Subjects who are pregnant or nursing (self-declared).
•13.Subjects with skin allergy history or atopic dermatitis or psoriasis.
•14.Subjects who are on any kind of supplements or taking nutraceuticals.
•15.Subject who are on any medication like blood thinners, excessive hormonal acne, cystic acne.
•16.Subject is an employee of the sponsor or the CRO.

发起方

Equipmed USA LLC